Moramide intermediate (β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.
![]() | |
Clinical data | |
---|---|
Trade names | β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid |
Other names | 4-Morpholinebutanoic acid, β-methyl-α,α-diphenyl-, moramide intermediate |
Routes of administration | N/A |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H25NO3 |
Molar mass | 339.435 g·mol−1 |
3D model (JSmol) | |
| |
|
In the United States, moramide intermediate is designated as a Schedule II controlled substance,[2] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[3]
In Australia, moramide intermediate is listed as a Schedule 9 (Prohibited Substance)[4]
See also
edit- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References
edit- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ^ Controlled Substances - by DEA Drug Code Number
- ^ "DEA Diversion Control Division".
- ^ "Therapeutic Goods (Poisons Standard—February 2024) Instrument 2024". Federal Register of Legislation. 23 January 2024. Retrieved 18 June 2024.